Skip to content

Study of Physical Health for Women With Posttraumatic Stress or Depression

Cardiovascular Risk in Relation to Posttraumatic Stress Disorder in Young Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01208844
Enrollment
59
Registered
2010-09-24
Start date
2008-06-30
Completion date
2012-08-31
Last updated
2015-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Healthy, Posttraumatic Stress Disorders, Stress, Psychological

Brief summary

The purpose of this study is to obtain a better understanding of how stress is related to health risks.

Detailed description

Participants complete up to two study visits of approximately 3-4 hours each. The first study visit involves an interview about life experiences and emotions. If the participant is eligible for the second assessment, the average length of time between visit 1 and visit 2 will be 1-7 days. The second visit included physical measurements such as cholesterol and blood pressure, performing math and speaking tasks, and surveys to help us learn about healthy behaviors and emotions. No further follow-up of participants is conducted beyond the two study visits.

Interventions

None listed

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Nova Southeastern University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Pre-menopausal * Must be able to speak and read English fluently

Exclusion criteria

* Specific medications and chronic diseases * History of heart attack (myocardial infarction) * Pregnant or given birth in last 3 months * Peri-menopausal or post-menopausal

Design outcomes

Primary

MeasureTime frameDescription
Number of Cardiovascular Risk FactorsSingle assessment timepointThis primary outcome will be assessed at the second study visit (1-7 days from first study visit for those who are eligible).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026